Re: Reports of Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Reports of Exempt Distribution

in response to

Re: Reports of Exempt Distribution

jonzobot

posted on Feb 23, 2023 05:05PM

jon.....you're right about that.

But the OTC stock market sees ZHCLF at a share price of 20 cents US.

Koo

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply